Table 4.

Comparative prospective ALL trials looking at older patients

Group and Trial	Age group	Number	CR rate (%)	OS (%)
				2yr	3yr	5yr	8yr
MRC/ECOG UKALL12/E2993	55–65	100	70	35	28	21	19
CALGB (Cumulative*) (Larson 2005)	>60	129	57		12
MD Anderson (Kantarjian et al, 2000)	>60	44	79			17
SWOG 8419 (Petersdorf et al, 2001)	50–84	85	41	-
GIMEMA 0288 (Annino et al, 2002)	50–60	121	68				15
PETHEMA ALL96 (Sancho et al, 2007)	56–67	33	58	39
SWOG 9400 (Pullarkat et al, 2008)	50–65	43	63			23
EWALL (Goekbuget et al, 2008)	56–73	40	85	-

^*CALGB 8811, 9111, 9311, 9511, and 19802